Veterinary Infusion Pumps Market Report Scope & Overview:

The Veterinary Infusion Pumps Market was valued at USD 375.84 Million in 2025 and is expected to reach USD 810.42 Million by 2035, growing at a CAGR of 7.52% from 2026–2035.

The global veterinary infusion pumps market is growing at a sustained and commercially significant pace. Veterinary infusion pumps are medical devices designed to deliver controlled volumes of fluids, medications, nutrients, and blood products to animals at precise flow rates and volumes, enabling fluid therapy, drug administration, parenteral nutrition, and continuous anaesthetic delivery in clinical veterinary settings. The market is driven by the increasing adoption of companion animals and rising spending on pet healthcare coupled with favourable insurance policies, which is anticipated to boost product demand, alongside continuous technological advancements in infusion pump precision, wireless connectivity, and drug library integration. The widespread use of continuous infusion pumps in postoperative care for consistent medication delivery and enhanced recovery outcomes, combined with the growing prevalence of chronic diseases among companion animals requiring ongoing fluid therapy, sustains commercial market expansion.

In 2024, Smiths Medical launched its updated Medfusion 3500 veterinary syringe pump with enhanced drug library integration for veterinary-specific medication protocols, wireless connectivity for remote monitoring by nursing staff, and improved alarm management reducing false alarm fatigue in busy veterinary ICU environments. The veterinary-specific drug library’s dosing guidance for canine, feline, and equine species creates clinical safety value whose precision medication delivery reduces dosing error risk that weight-based manual calculation creates in multi-species clinical environments.

Market Size and Forecast

• Market Size in 2026E: USD 404.07 Million

• Market Size by 2035: USD 810.42 Million

• CAGR: 7.52% from 2026 to 2035

• Fastest Growing Region: Asia Pacific

• Largest Region: North America

To Get more information On Veterinary Infusion Pumps Market - Request Free Sample Report

Veterinary Infusion Pumps Market Trends

• Smart veterinary infusion pumps with drug libraries and automated dose calculations are improving medication safety and reducing dosing errors.

• Wireless connectivity and remote monitoring features are enhancing workflow efficiency and patient management in veterinary critical care units.

• Growing pet insurance coverage is increasing adoption of advanced infusion therapies for companion animals.

• Miniaturized syringe pumps are expanding precise low-volume drug delivery for exotic and small animal species.

• Telemedicine-integrated pump monitoring is enabling remote clinical oversight and supporting adoption in rural and emergency veterinary settings.

The U.S. Veterinary Infusion Pumps Market Outlook

The U.S. Veterinary Infusion Pumps Market was valued at approximately USD 138.03 Million in 2025 and is expected to reach approximately USD 297.58 Million by 2035, growing at a CAGR of approximately 7.90%.

The U.S. is the most commercially significant veterinary infusion pumps market within North America’s dominant position. B. Braun Melsungen, Baxter International, Smiths Medical, Heliox Medical, and Biomedical Systems collectively serve the domestic veterinary hospital and clinic markets. The American Pet Products Association’s documentation of USD 147 billion in U.S. pet industry expenditure in 2025, with veterinary services representing the largest spending category, creates the world’s most commercially significant national veterinary infusion pump market. The growing U.S. veterinary pet insurance market’s progressive companion animal healthcare coverage expansion creates structured institutional procurement motivation that sustains above-average veterinary infusion pump adoption.

Mila International, a leading veterinary medical equipment company, expanded its veterinary-specific large volume infusion pump catalogue in 2024 with new multi-channel systems designed for simultaneous fluid therapy and medication infusion in equine and large animal critical care, addressing the unique clinical requirement of large animal veterinary medicine whose high infusion volumes and multiple concurrent drug delivery channels create specification motivation beyond small animal-focused pump design.

Veterinary Infusion Pumps Market Segment Analysis

• By Product Type, volumetric/large-volume infusion pumps segment dominated the veterinary infusion pumps market with approximately 55% share in 2025, while the syringe infusion pumps segment is the fastest growing.

• By Animal Type, companion animals segment dominated the veterinary infusion pumps market with approximately 56% share in 2025, while the livestock animals segment is the fastest growing.

• By Route of Administration, intravenous segment dominated the veterinary infusion pumps market, while the subcutaneous segment is the fastest growing.

• By End User, veterinary hospitals segment dominated the veterinary infusion pumps market, while the veterinary clinics segment is the fastest growing.

By Product Type, volumetric dominates, syringe grows fastest

Volumetric and large-volume infusion pumps retained the dominant product position with approximately 55% of the veterinary infusion pumps market in 2025. Volumetric pump’s commercial primacy reflects its role as the standard fluid therapy delivery device in veterinary critical care, surgical, and hospitalized patient management whose high-volume crystalloid and colloid infusion creates consistent procurement across veterinary hospitals of all sizes. Each veterinary ICU patient’s fluid therapy protocol creates volumetric pump procurement whose per-case commercial value reflects the treatment’s duration and complexity. Parenteral nutrition delivery, blood product transfusion, and continuous rate infusion’s high-volume character collectively create volumetric pump demand that syringe pump’s low-volume precision cannot address equivalently.

Syringe infusion pumps are the fastest-growing product type because the growing specialty veterinary practice’s precision medication delivery requirement for anaesthetic agents, vasopressors, insulin, and chemotherapy creates above-average syringe pump adoption whose precise low-volume delivery at 0.1-50 mL/hour creates clinical accuracy that volumetric alternatives cannot achieve equivalently. Each small companion animal or exotic patient whose body weight creates micro-dose calculation requirement creates syringe pump specification whose precision prevents the medication error risk that large-volume device alternatives create in small patient dosing contexts.

By Animal Type, companion animals dominate, livestock grows fastest

Companion animals retained the dominant animal type position with approximately 56% of the veterinary infusion pumps market in 2025. The pet humanization trend’s progressive elevation of companion animal healthcare quality creates structured above-average fluid therapy adoption whose per-patient clinical complexity mirrors human hospital care standards. Each dog or cat hospitalized for surgical procedure, trauma management, or critical illness creates volumetric and syringe pump procurement whose per-case fluid therapy creates commercial demand. The American Pet Products Association’s documentation of 66% U.S. household pet ownership creates the demographic foundation whose companion animal healthcare expenditure sustains commercial scale.

Livestock animals are the fastest-growing segment because food animal medicine’s progressive adoption of evidence-based fluid therapy, cattle emergency medicine’s intravenous fluid resuscitation, and the equine specialist’s advanced critical care programme create growing livestock infusion pump procurement that compounds with the global livestock industry’s animal health investment. Each dairy cattle operation whose postoperative abomasal displacement fluid therapy creates intravenous pump procurement sustains the segment’s fastest-growing commercial momentum.

Regional Analysis

North America Veterinary Infusion Pumps Market Insights

North America dominated the global veterinary infusion pumps market in 2025, accounting for approximately 39% of total market revenue, with the highest revenue share, driven by the most commercially advanced companion animal healthcare ecosystem, comprehensive pet insurance penetration, and the concentration of specialty veterinary referral hospital infrastructure. The United States accounts for approximately 87.4% of North American revenues through B. Braun, Baxter International, Smiths Medical, and Mila International’s commercial operations sustained by the extraordinary U.S. pet healthcare expenditure.

Canada contributes approximately 12.6% of North American revenues through its growing pet ownership market, the veterinary hospital network’s critical care programme, and the companion animal insurance market’s clinical adoption motivation.

Get Customized Report as per Your Business Requirement - Enquiry Now

Europe Veterinary Infusion Pumps Market Insights

Europe is a technically sophisticated veterinary infusion pumps market where the European pet population exceeding 340 million, the advanced veterinary hospital network, and B. Braun’s German commercial leadership create structured institutional demand. Germany accounts for approximately 22.3% of European revenues through its advanced companion animal veterinary hospital infrastructure, the livestock industry’s animal health investment, and B. Braun’s domestic commercial presence.

France, the United Kingdom, and the Netherlands are significant secondary markets where companion animal speciality hospital programmes, large animal equine medicine, and pet insurance create consistent veterinary infusion pump procurement.

Asia Pacific Veterinary Infusion Pumps Market Insights

Asia Pacific is the fastest-growing regional veterinary infusion pumps market, driven by China’s extraordinary companion animal market expansion, India’s rapidly growing pet ownership, Japan’s advanced veterinary medicine, and Australia’s mature veterinary hospital sector. China accounts for approximately 44.8% of Asia Pacific revenues through its rapidly growing companion animal ownership creating above-average veterinary critical care demand, the government’s animal health investment, and the growing specialty veterinary hospital network.

Japan’s mature companion animal veterinary hospital network, South Korea’s advanced pet healthcare market, and Australia’s comprehensive veterinary specialty sector create significant secondary markets.

MEA & Latin America Veterinary Infusion Pumps Market Insights

South Africa leads MEA revenues through its advanced companion animal veterinary sector, the equine industry’s critical care programme, and the growing pet healthcare investment. Brazil leads Latin American revenues through its large companion animal market, the growing veterinary hospital network, and the livestock industry’s animal health procurement.

Market Dynamics

Growth Drivers: Increasing companion animal adoption and pet humanization driving advanced veterinary care investment

The increasing adoption of companion animals and rising spending on pet healthcare coupled with favorable insurance policies is the veterinary infusion pumps market’s most commercially certain structural growth driver. The American Pet Products Association’s documentation of 66% U.S. household pet ownership and USD 147 billion in 2023 pet industry expenditure demonstrates the commercial scale whose veterinary services component creates infusion pump procurement motivation. Each pet owner whose insurance coverage authorizes above-standard clinical care for their critically ill animal creates infusion therapy adoption that compounds with pet insurance’s progressive market penetration. The pet humanization trend’s elevation of companion animal healthcare quality standard toward human medical equivalence creates structured premium veterinary equipment specification motivation.

Technological advancements in infusion pump precision, drug library integration, and wireless connectivity create clinical safety value whose precise medication delivery reduces dosing error risk in multi-species veterinary environments. Each new drug library update that incorporates evidence-based veterinary dosing protocols creates clinical adoption motivation whose patient safety benefit sustains institutional specification preference for smart pump alternatives over basic rate-setting devices.

Restraints: High capital cost of advanced smart pumps and limited veterinary clinical training infrastructure

Advanced veterinary infusion pump’s capital cost, encompassing multi-channel smart pump with drug library and wireless connectivity, creates adoption barriers for smaller veterinary practices and clinics whose equipment budget constrains premium specification investment. Each clinic whose patient case mix’s fluid therapy frequency does not justify premium smart pump investment creates specification preference for lower-cost gravity infusion or basic pump alternatives that moderates market growth below the technically optimal clinical deployment.

Limited veterinary nursing staff training infrastructure for advanced infusion pump management creates implementation barriers whose clinical competency gap moderates adoption of sophisticated smart pump features that simplification of clinical practice cannot provide equivalently.

Opportunities: Veterinary pet insurance expansion and smart IoT-connected infusion monitoring

Veterinary pet insurance market expansion represents the most commercially certain demand creation mechanism for advanced veterinary infusion therapy adoption. Each pet insurance policyholder whose coverage authorizes hospitalization and critical care creates clinical service utilization that compounds with insurance market penetration growth. The progressive improvement of veterinary insurance coverage’s lifetime benefit limit and critical care inclusion creates structured procurement motivation.

Smart IoT-connected veterinary infusion monitoring whose wireless pump status, patient vital sign, and drug delivery alert integration creates central monitoring capability creates above-average premium pump specification motivation in multi-patient veterinary ICU environments whose nursing efficiency improvement sustains investment ROI.

Recent Developments:

• 2024: Smiths Medical launched its updated Medfusion 3500 veterinary syringe pump in 2024 with enhanced veterinary-specific drug library integration, wireless connectivity for remote nursing monitoring, and improved alarm management for veterinary ICU environments.

• 2024: Mila International expanded its veterinary-specific large volume infusion pump catalogue in 2024 with new multi-channel systems for equine and large animal critical care, addressing simultaneous fluid therapy and medication infusion requirements in large animal veterinary medicine.

• 2024: B. Braun Melsungen launched a veterinary-specific configuration of its Infusomat Space infusion pump in 2024 with preconfigured veterinary drug libraries for canine, feline, equine, and exotic species dosing protocols, improving clinical safety through weight-based automatic dose calculation.

Veterinary Infusion Pumps Market Key Players are:

• B. Braun Melsungen AG

• Baxter International Inc.

• Smiths Medical (ICU Medical Inc.)

• Mila International Inc.

• Heliox Medical B.V.

• Caesarea Medical Electronics (CME)

• DRE Veterinary

• Vet Innovations Inc.

• Q Core Medical Ltd.

• Mindray Medical International Ltd.

• SurgiVet (Smiths Medical)

• Biomedical Systems Ltd.

• Digicare Animal Health (Biomedical Systems)

• Burtons Medical Equipment Ltd.

• Millpledge Veterinary

• Advanced Instruments LLC

• Syramed GmbH & Co. KG

• Fresenius Kabi AG

• Anixter International Inc.

• Practivet S.r.l.

Veterinary Infusion Pumps Market Report Scope: